Utah Medical Products
UTMD
68 hedge funds and large institutions have $221M invested in Utah Medical Products in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 15 closing their positions.
0.89% less ownership
Funds ownership: 72.11% → 71.22% (-0.89%)
3% less capital invested
Capital invested by funds: $228M → $221M (-$6.87M)
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
14% less funds holding
Funds holding: 79 → 68 (-11)
73% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$2.77M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$2.28M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$1.84M |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$713K |
| 5 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$601K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$3.63M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$856K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$828K |
| 4 |
Millennium Management
New York
|
-$735K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$697K |
UTMD Hedge Fund Activity: Q2 2021 in Review
68 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2021, worth a combined $221M — down 3% from $228M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of UTMD and 4 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 26 added.
The largest buyer was JP Morgan Chase, adding an estimated $2.77M. The largest seller was Russell Investments Group, cutting an estimated $3.63M.
- 68 institutional investors held Utah Medical Products (UTMD) as of Q2 2021, down from 79 in Q1 2021.
- Funds reported $221M of Utah Medical Products stock for Q2 2021, down 3% quarter-over-quarter.
- 4 funds opened new Utah Medical Products positions in Q2 2021 and 15 closed out, a net change of -11 holders.
- The largest Utah Medical Products buyer in Q2 2021 was JP Morgan Chase, an estimated $2.77M added.
- The largest Utah Medical Products seller in Q2 2021 was Russell Investments Group, an estimated $3.63M sold.
Based on aggregated 13F filings for Q2 2021.